Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-23-000242

Director sold 3,000 shares at $120.00 ($360,004)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ALTMAN STEVEN R Director 2023-12-12 Sale 10b5-1 −3,000 $120.00 $360,004 56,700 I: show line 1 in the form
Open-market sales · 3,000 sh · avg $120.00 · $360,004
Loading xslF345X05/edgardoc.xml…